Joseph H. Wender - 18 Nov 2025 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Director
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Joseph H. Wender
Issuer symbol
IONS
Transactions as of
18 Nov 2025
Net transactions value
+$390,720
Form type
4
Filing time
20 Nov 2025, 17:12:23 UTC
Previous filing
03 Nov 2025
Next filing
03 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WENDER JOSEPH H Director 2855 GAZELLE COURT, CARLSBAD By: Patrick R. O'Neil, attorney-in-fact For: Joseph H. Wender 19 Nov 2025 0001073384

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Options Exercise $390,720 +16,000 $24.42 16,000 18 Nov 2025 Direct F1
holding IONS Common Stock 64,035 18 Nov 2025 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONS Non-Qualified Stock Option (right to buy) Options Exercise $0 -16,000 -100% $0.000000 0 18 Nov 2025 Common Stock 16,000 $24.42 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/2026.